Cefmetazole

This classification denotes a cephalosporin antibiotic with the molecular formula C15H17N7O5S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3J962UJT8H, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((((cyanomethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-cis)- but generally known as cefmetazole, which bears US NIH Compound Identifier 42008. European Medicines Agency schedules Cefmetazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07399MIG. The term CEFMETAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules cefmetazole in its Anatomical Therapeutic Chemical (ATC) Classification. CEFMETAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cefmetazole under HS 29419000 and SITC 54139. As of Q4 2014, CEFMETAZOLE remains the US FDA Preferred Term for this commodity. Cefmetazole bears US NLM identifiers UMLS ID C0007550 and NCI Concept Code C65297. SMILES: S1C2N(C(=O)C2(OC)NC(=O)CSCC#N)C(=C(C1)CSC1N(NNN1)C)C(=O)O.